Device Trial Radar · NCT02492880
CoverEdge Algorithm Programming Study
Last checked: Nov 20, 2026Latest source record: Nov 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Jul 20, 2015
Primary completion
Feb 21, 2017
Study completion Feb 21, 2017
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Jul 9, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, on-label, multi-center, non-randomized, exploratory, single-arm study to characterize the effects of programming features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator (SCS) System using the CoverEdge™ surgical lead.
Conditions
- Chronic Pain
Interventions
Precision Spectra™ SCS system programming featuresDevice
Precision Spectra™ SCS system programming features using the CoverEdge surgical lead.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Paresthesia Distribution From Subject Completed Paresthesia Drawing QuestionnaireTime frame: minimum 25 days post IPG implant
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Barolat Neuroscience
Denver, Colorado
Albany Medical Center
Albany, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.